Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)
Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –
Veracyte profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Veracyte's profit margin for the twelve months ending Jun 30, 2026 was 20.4%. For fiscal 2025 it was 12.8%, against 5.4% the year before. The highest annual figure on record is 12.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.8% | +7.4 |
| FY2024 | Dec 31, 2024 | 5.4% | +26.0 |
| FY2023 | Dec 31, 2023 | -20.6% | −8.3 |
| FY2022 | Dec 31, 2022 | -12.3% | +22.1 |
| FY2021 | Dec 31, 2021 | -34.4% | −4.7 |
| FY2020 | Dec 31, 2020 | -29.7% | −19.2 |
| FY2019 | Dec 31, 2019 | -10.5% | +14.5 |
| FY2018 | Dec 31, 2018 | -25.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 17.0% | +17.7 |
| Q1 FY2026 | Mar 31, 2026 | 20.6% | +14.5 |
| Q4 FY2025 | Dec 31, 2025 | 29.3% | +24.9 |
| Q3 FY2025 | Sep 30, 2025 | 14.5% | +1.4 |
| Q2 FY2025 | Jun 30, 2025 | -0.8% | −5.8 |
| Q1 FY2025 | Mar 31, 2025 | 6.2% | +8.1 |
| Q4 FY2024 | Dec 31, 2024 | 4.3% | +33.1 |
| Q3 FY2024 | Sep 30, 2024 | 13.1% | +45.9 |
| Q2 FY2024 | Jun 30, 2024 | 5.0% | +14.3 |
| Q1 FY2024 | Mar 31, 2024 | -1.9% | +7.9 |
| Q4 FY2023 | Dec 31, 2023 | -28.8% | −24.0 |
| Q3 FY2023 | Sep 30, 2023 | -32.9% | −21.3 |
| Q2 FY2023 | Jun 30, 2023 | -9.3% | +3.8 |
| Q1 FY2023 | Mar 31, 2023 | -9.8% | +11.5 |
| Q4 FY2022 | Dec 31, 2022 | -4.8% | +10.8 |
| Q3 FY2022 | Sep 30, 2022 | -11.5% | +11.9 |
| Q2 FY2022 | Jun 30, 2022 | -13.1% | +3.3 |
| Q1 FY2022 | Mar 31, 2022 | -21.3% | +92.7 |
| Q4 FY2021 | Dec 31, 2021 | -15.6% | +7.7 |
| Q3 FY2021 | Sep 30, 2021 | -23.4% | −10.2 |
| Q2 FY2021 | Jun 30, 2021 | -16.4% | +36.8 |
| Q1 FY2021 | Mar 31, 2021 | -114.1% | −76.4 |
| Q4 FY2020 | Dec 31, 2020 | -23.3% | +1.8 |
| Q3 FY2020 | Sep 30, 2020 | -13.3% | −10.9 |
| Q2 FY2020 | Jun 30, 2020 | -53.3% | −45.0 |
| Q1 FY2020 | Mar 31, 2020 | -37.6% | −31.2 |
| Q4 FY2019 | Dec 31, 2019 | -25.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -2.4% | – |
| Q2 FY2019 | Jun 30, 2019 | -8.3% | – |
| Q1 FY2019 | Mar 31, 2019 | -6.5% | – |
See a number that looks wrong?